Paulson & Co’s Dynavax Technologies DVAX Stock Holding History

Paulson & Co’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-554,600	Closed	-$5.35M	–	62
2017 Q2	$5.35M	Buy	554,600 +91,600	+20%	+$595K	0.07%	78
2017 Q1	$2.75M	Buy	463,000 +289,000	+166%	+$1.39M	0.04%	81
2016 Q4	$687K	Hold	174,000	–	–	0.01%	95
2016 Q3	$1.82M	Hold	174,000	–	–	0.02%	85
2016 Q2	$2.54M	Sell	174,000 -25,700	-13%	-$439K	0.03%	71
2016 Q1	$3.84M	Buy	199,700 +65,900	+49%	+$1.33M	0.03%	73
2015 Q4	$3.23M	Buy	+133,800	New	+$3.35M	0.02%	62

Other funds holding DVAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Paulson & Co's DVAX Position: Q3 2017 in Review

Paulson & Co sold out of Dynavax Technologies (DVAX) in Q3 2017, closing a stake of 554,600 shares — an estimated $5.35M sold.

Paulson & Co first reported a position in DVAX in Q4 2015 and held it in 7 quarters. The position peaked at $5.35M in Q2 2017. 119 funds tracked by Wall St. Rank hold DVAX as of Q3 2017.

Paulson & Co reported no remaining Dynavax Technologies position as of Q3 2017 after selling out during the quarter.
Paulson & Co sold 554,600 Dynavax Technologies shares in Q3 2017, an estimated $5.35M.
Paulson & Co first reported a position in Dynavax Technologies in Q4 2015 and held it in 7 quarters.
Paulson & Co's Dynavax Technologies position peaked at $5.35M in Q2 2017.
119 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2017.

Based on Paulson & Co's 13F filing for Q3 2017, filed 14 Nov 2017.